Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2004 | |
| Cash Flows From Operating Activities | |
| Net Income | -5,580 |
| Depreciation Amortization | 120 |
| Other Working Capital | 20 |
| Other Operating Activity | 600 |
| Operating Cash Flow | $-4,840 |
| Cash Flows From Investing Activities | |
| PPE Investments | -470 |
| Other Investing Activity | -4,000 |
| Investing Cash Flow | $-4,470 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 14,680 |
| Financing Cash Flow | $14,680 |
| Exchange Rate Effect | -40 |
| Beginning Cash Position | 4,120 |
| End Cash Position | 9,430 |
| Net Cash Flow | $5,310 |
| Free Cash Flow | |
| Operating Cash Flow | -4,840 |
| Free Cash Flow | -4,840 |